A case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with Rituximab-based combination chemotherapy

Ovarian involvement as primary or secondary lymphomatous process is extremely uncommon. In most cases, the diagnosis is usually not suspected initially and is confirmed only after detailed histopathological evaluation. We report a patient with primary ovarian diffuse large B-cell lymphoma (DLBCL) an...

Full description

Saved in:
Bibliographic Details
Main Authors: N S Ghadyalpatil, R Chandrasekar, D Snehalatha, B M Reddy
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2011-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2011;volume=32;issue=4;spage=207;epage=210;aulast=Ghadyalpatil
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850228190451073024
author N S Ghadyalpatil
R Chandrasekar
D Snehalatha
B M Reddy
author_facet N S Ghadyalpatil
R Chandrasekar
D Snehalatha
B M Reddy
author_sort N S Ghadyalpatil
collection DOAJ
description Ovarian involvement as primary or secondary lymphomatous process is extremely uncommon. In most cases, the diagnosis is usually not suspected initially and is confirmed only after detailed histopathological evaluation. We report a patient with primary ovarian diffuse large B-cell lymphoma (DLBCL) and associated auto-immune hemolytic anemia (AIHA) who achieved complete remission after treatment with Rituximab-cyclophosphamide-doxorubicin-vincristine and prednisolone (R-CHOP) chemotherapy. This patient was a 50 year old female, who presented with fever, abdominal pain, vomiting, weight loss and anemia. Computed tomography scan of the abdomen and pelvis revealed a large left ovarian mass with bilateral hydronephrosis. We performed exploratory laparotomy and partial resection of the mass was done due to the adhesions. Histopathology confirmed the diagnosis of DLBCL. After six R-CHOP chemotherapy cycles, patient achieved complete response with correction of anemia. To our knowledge, this may be the first case report till date of primary ovarian DLBCL with AIHA treated with R-CHOP chemotherapy who achieved complete remission in terms of primary disease as well as hemolytic anemia.
format Article
id doaj-art-f1ef29b9aa9d4e1bacd9bc6d5d81b80c
institution OA Journals
issn 0971-5851
language English
publishDate 2011-01-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series Indian Journal of Medical and Paediatric Oncology
spelling doaj-art-f1ef29b9aa9d4e1bacd9bc6d5d81b80c2025-08-20T02:04:36ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58512011-01-0132420721010.4103/0971-5851.95142A case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with Rituximab-based combination chemotherapyN S GhadyalpatilR ChandrasekarD SnehalathaB M ReddyOvarian involvement as primary or secondary lymphomatous process is extremely uncommon. In most cases, the diagnosis is usually not suspected initially and is confirmed only after detailed histopathological evaluation. We report a patient with primary ovarian diffuse large B-cell lymphoma (DLBCL) and associated auto-immune hemolytic anemia (AIHA) who achieved complete remission after treatment with Rituximab-cyclophosphamide-doxorubicin-vincristine and prednisolone (R-CHOP) chemotherapy. This patient was a 50 year old female, who presented with fever, abdominal pain, vomiting, weight loss and anemia. Computed tomography scan of the abdomen and pelvis revealed a large left ovarian mass with bilateral hydronephrosis. We performed exploratory laparotomy and partial resection of the mass was done due to the adhesions. Histopathology confirmed the diagnosis of DLBCL. After six R-CHOP chemotherapy cycles, patient achieved complete response with correction of anemia. To our knowledge, this may be the first case report till date of primary ovarian DLBCL with AIHA treated with R-CHOP chemotherapy who achieved complete remission in terms of primary disease as well as hemolytic anemia.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2011;volume=32;issue=4;spage=207;epage=210;aulast=GhadyalpatilHemolytic anemiaovarian lymphomaRituximab
spellingShingle N S Ghadyalpatil
R Chandrasekar
D Snehalatha
B M Reddy
A case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with Rituximab-based combination chemotherapy
Indian Journal of Medical and Paediatric Oncology
Hemolytic anemia
ovarian lymphoma
Rituximab
title A case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with Rituximab-based combination chemotherapy
title_full A case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with Rituximab-based combination chemotherapy
title_fullStr A case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with Rituximab-based combination chemotherapy
title_full_unstemmed A case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with Rituximab-based combination chemotherapy
title_short A case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with Rituximab-based combination chemotherapy
title_sort case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with rituximab based combination chemotherapy
topic Hemolytic anemia
ovarian lymphoma
Rituximab
url http://www.ijmpo.org/article.asp?issn=0971-5851;year=2011;volume=32;issue=4;spage=207;epage=210;aulast=Ghadyalpatil
work_keys_str_mv AT nsghadyalpatil acaseofprimaryovarianlymphomawithautoimmunehemolyticanemiaachievingcompleteresponsewithrituximabbasedcombinationchemotherapy
AT rchandrasekar acaseofprimaryovarianlymphomawithautoimmunehemolyticanemiaachievingcompleteresponsewithrituximabbasedcombinationchemotherapy
AT dsnehalatha acaseofprimaryovarianlymphomawithautoimmunehemolyticanemiaachievingcompleteresponsewithrituximabbasedcombinationchemotherapy
AT bmreddy acaseofprimaryovarianlymphomawithautoimmunehemolyticanemiaachievingcompleteresponsewithrituximabbasedcombinationchemotherapy
AT nsghadyalpatil caseofprimaryovarianlymphomawithautoimmunehemolyticanemiaachievingcompleteresponsewithrituximabbasedcombinationchemotherapy
AT rchandrasekar caseofprimaryovarianlymphomawithautoimmunehemolyticanemiaachievingcompleteresponsewithrituximabbasedcombinationchemotherapy
AT dsnehalatha caseofprimaryovarianlymphomawithautoimmunehemolyticanemiaachievingcompleteresponsewithrituximabbasedcombinationchemotherapy
AT bmreddy caseofprimaryovarianlymphomawithautoimmunehemolyticanemiaachievingcompleteresponsewithrituximabbasedcombinationchemotherapy